Positive for hepatitis B virus markers in patients with liver function observed during anti-tuberculosis.doc

 PAGE \* MERGEFORMAT 8 Positive for hepatitis B virus markers in patients with liver function observed during anti-tuberculosis [Abstract] of 50 cases of pulmonary tuberculosis with hepatitis B virus markers (HBVM) positive for anti-tuberculosis treatment in patients with liver function test, liver function was 50%, while the negative is 2:0%, P lt;0.01, both a significant difference. Tip TB treatment in TB patients must check HBVM, on the positive choice of liver damage or damage to the small free anti-TB drugs. [Keywords:] Tuberculosis / lung markers of hepatitis B virus anti-TB drugs 1 Clinical data Sources to 1.1 cases of early diagnosis of pulmonary tuberculosis patients in treatment HBVM testing, randomly selected patients with HBVM positive and negative patients, 50 patients, male 76, female 24 cases, all cases were over the age of 20 pulmonary tuberculosis patients were .100 No hepatitis B history. 1.2 The observation group and control group of patients before treatment and liver function test results HBVM jaundice index (), thymol turbidity test (TTT), alanine aminotransferase (GPT) were normal. HBVM control group of 50 patients tested were negative indicators. 50 cases observed indicators HBVM test positive cases: 13 patients with HBsAg (+), 15 HBsAg (+), HBeAg (+), HBcAb (+), 8 HBsAg (+), HBcAb (+), 8 HBeAg (+), HBcAg (+), 6 HBcAb (+). 1.3 TB treatment liver function tests were 100 cases of pulmonary tuberculosis patients treated with 2SRZH/4RH program, the same dose. Patients according to clinical need or regular liver function. HNVM negative patients 50 patients 3 months after anti-TB treatment GPT increased in 1 case, other indicators of normal, 2.0%, review HBVM still negative. 13 cases of HBsAg (+) patients after 3 months of treatment increased in five cases, and were higher than 100, the highest of 250 (I have normal lt;25), but and TTT were normal, measured against. HBcIgM was